Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Predictive Oncology Debt to Equity Ratio 2010-2024 | POAI

Current and historical debt to equity ratio values for Predictive Oncology (POAI) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Predictive Oncology debt/equity for the three months ending December 31, 2024 was 0.00.
  
Predictive Oncology Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-12-31 $0.01B $0.00B -25.54
2024-09-30 $0.01B $0.00B 2.81
2024-06-30 $0.01B $0.00B 1.59
2024-03-31 $0.01B $0.00B 1.62
2023-12-31 $0.01B $0.01B 0.74
2023-09-30 $0.01B $0.01B 0.56
2023-06-30 $0.01B $0.02B 0.43
2023-03-31 $0.01B $0.02B 0.35
2022-12-31 $0.00B $0.02B 0.18
2022-09-30 $0.00B $0.03B 0.12
2022-06-30 $0.00B $0.03B 0.09
2022-03-31 $0.00B $0.04B 0.08
2021-12-31 $0.00B $0.04B 0.09
2021-09-30 $0.00B $0.05B 0.07
2021-06-30 $0.00B $0.05B 0.07
2021-03-31 $0.00B $0.04B 0.12
2020-12-31 $0.01B $0.00B 3.94
2020-09-30 $0.01B $0.01B 1.06
2020-06-30 $0.02B $0.01B 1.35
2020-03-31 $0.02B $0.01B 1.42
2019-12-31 $0.01B $0.01B 0.99
2019-09-30 $0.01B $0.02B 0.54
2019-06-30 $0.01B $0.02B 0.45
2019-03-31 $0.01B $0.00B 71.67
2018-12-31 $0.00B $0.00B 68.33
2018-09-30 $0.00B $0.00B 0.79
2018-06-30 $0.00B $0.00B 0.19
2018-03-31 $0.00B $0.01B 0.15
2017-12-31 $0.00B $0.00B 0.35
2017-09-30 $0.00B $0.00B 0.53
2017-06-30 $0.00B $0.00B 0.42
2017-03-31 $0.00B $0.00B 0.37
2016-12-31 $0.00B $0.00B 2.04
2016-09-30 $0.00B $0.00B 165.70
2016-06-30 $0.00B $0.00B 2.69
2016-03-31 $0.00B $0.00B 0.60
2015-12-31 $0.00B $0.00B 0.37
2015-09-30 $0.00B $0.01B 0.45
2015-06-30 $0.01B $-0.01B -1.12
2015-03-31 $0.01B $-0.01B -1.13
2014-12-31 $0.01B $-0.01B -1.16
2014-09-30 $0.01B $0.00B -1.32
2014-06-30 $0.00B $0.00B -1.30
2014-03-31 $0.00B $0.00B -1.60
2013-12-31 $0.00B $0.00B -1.18
2013-09-30 $0.00B $0.00B -1.53
2013-06-30 $0.00B $0.00B -1.13
2013-03-31 $0.00B $0.00B -1.29
2012-12-31 $0.00B $0.00B -1.11
2012-09-30 $0.00B $0.00B -1.20
2012-06-30 $0.00B $0.00B -1.17
2012-03-31 $0.00B $0.00B -1.12
2011-12-31 $0.00B $0.00B -1.17
2011-09-30 $0.00B $0.00B -1.11
2011-06-30 $0.00B $0.00B -1.10
2011-03-31 $0.00B $0.00B -1.22
2010-12-31 $0.00B $0.00B -1.08
2010-09-30 $0.00B $0.00B -1.09
2010-06-30 $0.00B $0.00B -1.10
2010-03-31 $0.00B $0.00B -1.11
2009-12-31 $0.00B $0.00B -1.12
2009-09-30 $0.00B $0.00B -1.18
2009-06-30 $0.00B $0.00B 0.00
2009-03-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.009B $0.002B
Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.774B 53.56
Hims & Hers Health (HIMS) United States $11.630B 121.74
Tempus AI (TEM) United States $10.119B 0.00
Inspire Medical Systems (INSP) United States $4.616B 72.12
IRhythm Technologies (IRTC) United States $4.348B 0.00
Privia Health (PRVA) United States $2.829B 212.00
Enovis (ENOV) United States $1.955B 12.10
Clover Health Investments (CLOV) United States $1.926B 0.00
Schrodinger (SDGR) United States $1.732B 0.00
Phreesia (PHR) United States $1.434B 0.00
Azenta (AZTA) United States $1.154B 53.74
Omnicell (OMCL) United States $1.154B 20.35
10x Genomics (TXG) United States $1.016B 0.00
Fulgent Genetics (FLGT) United States $0.568B 0.00
Butterfly Network (BFLY) United States $0.530B 0.00
Talkspace (TALK) United States $0.512B 152.00
Veradigm (MDRX) United States $0.466B 0.00
Standard BioTools (LAB) United States $0.387B 0.00
TruBridge (TBRG) United States $0.381B 850.00
Claritev (CTEV) United States $0.344B 0.00
Health Catalyst (HCAT) United States $0.279B 0.00
Nyxoah SA (NYXH) Belgium $0.215B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.200B 0.00
Pulmonx (LUNG) United States $0.148B 0.00
American Well (AMWL) United States $0.106B 0.00
Retrieve Medical Holdings (RMHI) United States $0.094B 0.00
EUDA Health Holdings (EUDA) Singapore $0.092B 0.00
MDxHealth SA (MDXH) Belgium $0.081B 0.00
CareCloud (CCLD) United States $0.080B 3.03
111 (YI) China $0.064B 0.00
HeartBeam (BEAT) United States $0.063B 0.00
P3 Health Partners (PIII) United States $0.062B 0.00
Outset Medical (OM) United States $0.042B 0.00
Zepp Health (ZEPP) Netherlands $0.038B 0.00
Zhongchao (ZCMD) China $0.030B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.015B 0.00
Streamline Health Solutions (STRM) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Precipio (PRPO) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Movano (MOVE) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00